This information was published on 2026-04-02T03:13:31 for IP Right Filed Published.
| Field | Value |
| (210) | 2641308 (IR 1910426) |
| (220) |
02 Mar 2026
|
| (300) |
GB, 23 Feb 2026, UK000043440005
|
| (500) |
The applicant has advised that the words in the Mark have no meaning in English
|
| (511) (510) |
Class 5
Pharmaceutical and medicinal preparations and substances; vaccines. |
| (540) | QUILBILA |
| (550) | Word |
| (730) |
Glaxo Group Limited
|
Find out more about publications on the About page.